Next report date
Report period
Q1 2024
EPS estimate
−0.20EUR
Revenue estimate
20.24 MEUR
−1.180EUR
−95.01 MEUR
52.89 MEUR
71.66 M
About IMMATICS N.V.
Sector
Industry
CEO
Harpreet Singh-Jasuja
Website
Headquarters
Tuebingen
Employees (FY)
343
Founded
2020
ISIN
NL0015285941
FIGI
BBG00VTXH4V6
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IMMATICS N.V. stocks are traded under the ticker 4A3.
IMMATICS N.V. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4A3 earnings for the last quarter are −0.32 EUR per share, whereas the estimation was −0.36 EUR resulting in a 11.48% surprise. The estimated earnings for the next quarter are −0.32 EUR per share. See more details about IMMATICS N.V. earnings.
IMMATICS N.V. revenue for the last quarter amounts to 5.93 M EUR despite the estimated figure of 10.89 M EUR. In the next quarter revenue is expected to reach 13.79 M EUR.
Yes, you can track IMMATICS N.V. financials in yearly and quarterly reports right on TradingView.
4A3 net income for the last quarter is −25.48 M EUR, while the quarter before that showed −27.26 M EUR of net income which accounts for 6.54% change. Track more IMMATICS N.V. financial stats to get the full picture.
No, 4A3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4A3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMATICS N.V. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 343.00 employees. See our rating of the largest employees — is IMMATICS N.V. on this list?
We've gathered analysts' opinions on IMMATICS N.V. future price: according to them, 4A3 price has a max estimate of 18.41 EUR and a min estimate of 13.12 EUR. Read a more detailed IMMATICS N.V. forecast: see what analysts think of IMMATICS N.V. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMMATICS N.V. EBITDA is −93.62 M EUR, and current EBITDA margin is −177.10%. See more stats in IMMATICS N.V. financial statements.